How Frank Lowy’s Tel Aviv think tank says the Gaza war can end Once Israel ends the war, an Arab-Egyptian reconstruction plan would have to be modified to ensure Hamas cannot regroup and take ...

Iran launched dozens of missiles on Friday and hit several sites in Israel, after waves of Israeli strikes against Iran’s nuclear facilities and military leaders.

Regeneron’s stock is having its worst day in 14 years after the failure of late-stage trial of its COPD treatment, after analysts had just placed a high probability of a positive result.

Even as it was shipping weapons abroad, Israel also received at least $17.9 billion in military aid, including weapons, from the United States in the 12 months after Hamas led a deadly invasion on ...

Regeneron Pharmaceuticals’ Debt total was $2.7 Billion at the conclusion of the most recent quarter, while its market capitalization is $52 Billion (as of 5/30/2025).

Lowy is confident in Libtayo’s future growth, with Regeneron eying further indications. “We believe Libtayo has significant long-term growth potential in CSCC. We estimate that approximately 10,000 ...

Libtayo demonstrated a 68% reduction in the risk of disease recurrence or death, the primary endpoint of the trial (p<0.0001) Libtayo also demonstrated 80% and 65% reductions in the risk of ...

“These results show the continued promise of Libtayo in non-melanoma skin cancers,” said Israel Lowy, M.D., Ph.D., Clinical Development Unit Head, Oncology, at Regeneron.

Regulatory applications have been submitted in the United States and European Union. TARRYTOWN, N.Y., May 31, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced ...

In an interview earlier this week, Israel Lowy, M.D., Ph.D., clinical development unit head, oncology, at Regeneron, said the company has already filed applications with the FDA and the European ...

The headquarters of the biotechnology company 23andMe is seen in Sunnyvale, Calif., on Tuesday, June 7, 2022. Regeneron Pharmaceuticals announced Monday its purchase of genetics and biotechnology ...